BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ER, estrogen receptor AND Treatment
763 results:

  • 1. 25-hydroxycholesterol promotes proliferation and metastasis of lung adenocarcinoma cells by regulating ERβ/TNFRSF17 axis.
    He M; Jiang W; Li X; Liu H; Ren H; Lin Y
    BMC Cancer; 2024 Apr; 24(1):505. PubMed ID: 38649856
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer.
    Zhang YZ; Lai HL; Huang C; Jiang ZB; Yan HX; Wang XR; Xie C; Huang JM; Ren WK; Li JX; Zhai ZR; Yao XJ; Wu QB; Leung EL
    Phytomedicine; 2024 Jun; 128():155431. PubMed ID: 38537440
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. XAF1 overexpression inhibits the malignant progression and cisplatin resistance of NSCLC by activating endoplasmic reticulum stress.
    Chen B; Cheng Y; Wu H; Yao J
    Mol Biol Rep; 2024 Mar; 51(1):435. PubMed ID: 38520543
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [A Case of Breast cancer That Developed Pulmonary Tumor Thrombotic Microangiopathy during Adjuvant Chemotherapy].
    Okano K; Suzuki T; Abe A; Itaya A; Kameyama Y; Matsumoto S; Hakamada K
    Gan To Kagaku Ryoho; 2024 Mar; 51(3):283-285. PubMed ID: 38494809
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Systematic identification of a synthetic lethal interaction in brain-metastatic lung adenocarcinoma.
    Moon JW; Hong BJ; Kim SK; Park MS; Lee H; Lee J; Kim MY
    Cancer Lett; 2024 Apr; 588():216781. PubMed ID: 38494150
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
    Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
    BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Combination of Polygonatum Rhizoma and Scutellaria baicalensis triggers apoptosis through downregulation of PON
    Liu H; Yue L; Li Y; Zheng T; Zhang W; Li C; Zhuang W; Fan L
    Environ Toxicol; 2024 May; 39(5):3172-3187. PubMed ID: 38348599
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [A Case of Combined Use of Mohs Paste and Radiation Therapy for Advanced Breast cancer with Bleeding].
    Yanagawa T; Yamaura M; Nomura H; Oshima K; Katsuyama S; Shinke G; Kinoshita M; Ikeshima R; Hiraki M; Ohmura Y; Sugimura K; Masuzawa T; Hata T; Takeda Y; Murata K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1839-1841. PubMed ID: 38303225
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [A Case of Triple Negative Breast cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
    Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [A Case of Severe Drug-Induced lung Injury during Preoperative Chemotherapy for Breast cancer in the Early Stages of the COVID-19 Epidemic].
    Hirata A; Terasawa R; Takashima Y; Morita S; Kimura K; Iwamoto M; Hayashi M
    Gan To Kagaku Ryoho; 2023 Dec; 50(12):1343-1345. PubMed ID: 38247078
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Investigation of co-treatment multi-targeting approaches in breast cancer cell lines.
    Longaray JB; Dias CK; Scholl JN; Battastini AMO; Figueiró F
    Eur J Pharmacol; 2024 Mar; 966():176328. PubMed ID: 38237714
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Association of metastatic pattern in breast cancer with tumor and patient-specific factors: a nationwide autopsy study using artificial intelligence.
    Kazemzadeh F; Snoek JAA; Voorham QJ; van Oijen MGH; Hugen N; Nagtegaal ID
    Breast Cancer; 2024 Mar; 31(2):263-271. PubMed ID: 38133738
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. USP7-mediated ERβ stabilization mitigates ROS accumulation and promotes osimertinib resistance by suppressing PRDX3 SUMOylation in non-small cell lung carcinoma.
    Meng Y; Lin W; Wang N; Wei X; Mei P; Wang X; Zhang C; Huang Q; Liao Y
    Cancer Lett; 2024 Feb; 582():216587. PubMed ID: 38097136
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study).
    Watanabe S; Furuya N; Nakamura A; Shiihara J; Nakachi I; Tanaka H; Nakao M; Minato K; Seike M; Sasaki S; Kisohara A; Takeuchi S; Honda R; Takamura K; Kagamu H; Yoshimura K; Kobayashi K; Kikuchi T
    Eur J Cancer; 2024 Jan; 197():113469. PubMed ID: 38061214
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A Case Report of a Rare ER+, PR- Pure Metaplastic Breast Squamous Cell Carcinoma with HER2 Overexpression.
    Adam SA; Kamaruddin KN; Abd Shukor N; Abdullah Suhaimi SN; Ismail F; Md Yasin M
    Am J Case Rep; 2023 Dec; 24():e941448. PubMed ID: 38048289
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. estrogen receptor-mediated health benefits of phytochemicals: a review.
    Li J; Yu J; Zou H; Zhang J; Ren L
    Food Funct; 2023 Dec; 14(24):10681-10699. PubMed ID: 38047630
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Association between ER, PR, HER2, and ER-/PR+ Expression and lung cancer Subsequent in Breast cancer Patients: A Retrospective Cohort Study Based on SEER Database.
    Shao HY; Hao BT; Gao FX
    Breast J; 2023; 2023():7028189. PubMed ID: 38021219
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Molecular Basis for Selectivity of the Cytotoxic Response of lung Adenocarcinoma Cells to Cold Atmospheric Plasma.
    Biryukov M; Semenov D; Kryachkova N; Polyakova A; Patrakova E; Troitskaya O; Milakhina E; Poletaeva J; Gugin P; Ryabchikova E; Zakrevsky D; Schweigert I; Koval O
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002354
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Therapeutic, diagnostic and prognostic values of TRIM proteins in prostate cancer.
    Li X; Bai Y; Feng K; Chu Z; Li H; Lin Z; Tian L
    Pharmacol Rep; 2023 Dec; 75(6):1445-1453. PubMed ID: 37921966
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cisplatin-activated ERβ/DCAF8 positive feedback loop induces chemoresistance in non-small cell lung cancer via PTEN/Akt axis.
    Hu Y; Xu Y; Zhang T; Han Q; Li L; Liu M; Li N; Shao G
    Drug Resist Updat; 2023 Nov; 71():101014. PubMed ID: 37913652
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 39.